0000899243-21-016935.txt : 20210423 0000899243-21-016935.hdr.sgml : 20210423 20210423200013 ACCESSION NUMBER: 0000899243-21-016935 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210319 FILED AS OF DATE: 20210423 DATE AS OF CHANGE: 20210423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Falconer Ester CENTRAL INDEX KEY: 0001844479 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 21851131 MAIL ADDRESS: STREET 1: C/O ABCELLERA BIOLOGICS INC. STREET 2: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbCellera Biologics Inc. CENTRAL INDEX KEY: 0001703057 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 BUSINESS PHONE: (604) 559-9005 MAIL ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-19 0 0001703057 AbCellera Biologics Inc. ABCL 0001844479 Falconer Ester C/O ABCELLERA BIOLOGICS INC. 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 BRITISH COLUMBIA, CANADA 0 1 0 0 Chief Technology Officer Common Shares 2021-03-19 4 M 0 1000000 0.0343 A 1000000 D Share Option (right to buy) 0.0343 2021-03-19 4 M 0 1000000 0.00 D 2025-08-04 Common Shares 1000000 0 D The exercise price reported above was converted from the Canadian exercise price of CAD $0.0450 using an exchange rate on August 4, 2015 of CAD $1.313 = US $1.00. As of the date of the transaction, the option was fully vested and exercisable. /s/ Tryn Stimart, attorney-in-fact 2021-04-23